| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $281.1M | — | +3.9% |
| Cost of Revenue | $114.6M | — | -0.2% |
| Gross Profit | $166.6M | — | +6.9% |
| R&D Expense | $36.9M | — | +10.0% |
| SG&A Expense | $30.3M | — | -46.6% |
| Operating Income | $51.4M | — | +151.8% |
| Interest Expense | $16.0M | — | -5.4% |
| Pre-tax Income | $37.8M | — | +576.3% |
| Income Tax | $6.7M | — | +822.0% |
| Net Income | $31.1M | — | +539.8% |
| EPS (Basic) | $0.68 | — | +580.0% |
| EPS (Diluted) | $0.67 | — | +570.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.1M | -12.4% | -8.4% |
| Accounts Receivable | $75.7M | -6.0% | -3.1% |
| Current Assets | $642.2M | -31.0% | +2.4% |
| Total Assets | $2.11B | -11.8% | +0.3% |
| Current Liabilities | $866.7M | -26.7% | +0.3% |
| Long-term Debt | $1.16B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $51.5M | — | +3607.4% |
| Capital Expenditures | $1.7M | — | +142.4% |
| Investing Cash Flow | -$14.5M | — | +44.1% |
| Financing Cash Flow | -$342.8M | — | -3.9% |
| Free Cash Flow | $49.8M | — | +7013.0% |
| -1.6% |
| Total Liabilities | $2.07B | -10.0% | +0.3% |
| Stockholders' Equity | $34.6M | -59.4% | +4.2% |